Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
New Monoclonal Antibody Class Shows Promise for Migraine
A potential first-in-class therapy for migraine prevention has shown promise in a phase 2a proof-of-concept study, with a single infusion reducing migraine frequency over 4 weeks. The drug Lu AG09222 from Lundbeck is an investigational monoclonal antibody that targets a…
English